Cambridge Massachusetts based Carmine Therapeutics is raising $13,697,828.00 in New Equity Investment.
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Carmine Therapeutics is raising $13,697,828.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Donald Haut played a…